Bertout J, Thomas-Tikhonenko A (2006) Infection and neoplastic growth 101: the required reading for microbial pathogens aspiring to cause cancer. Cancer Treat Res 130:167–197 ArticlePubMedCAS Google Scholar
Clarke DD, Mycek MJ, Neidle A, Waelsch H (1957) The incorporation of amines into proteins. Arch Biochem Biophys 79:338–354 Article Google Scholar
Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D (1997) Identification of tissue transglutaminase as the autoantigen of coeliac disease. Nat Med 3:797–801 ArticlePubMedCAS Google Scholar
Dubin PJ, McAllister F, Kolls JK (2007) Is cystic fibrosis a TH17 disease? Inflamm Res 56:221–227 ArticlePubMedCAS Google Scholar
Elli L, Bergamini CM, Bardella MT, Schuppan D (2009) Transglutaminases in inflammation and fibrosis of the gastrointestinal tract and the liver. Dig Liver Dis 41:541–550 ArticlePubMedCAS Google Scholar
Facchiano F, Facchiano A, Facchiano AM (2006) The role of transglutaminase-2 and its substrates in human diseases. Front Biosci 11:1758–1773 ArticlePubMedCAS Google Scholar
Fesik SW (2005) Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer 5:876–885 ArticlePubMedCAS Google Scholar
Fok JY, Ekmekcioglu S, Mehta K (2006) Implications of tissue transglutaminase expression in malignant melanoma. Mol Cancer Ther 5:1493–1503 ArticlePubMedCAS Google Scholar
Frese-Schaper M, Schardt JA, Sakai T, Carboni GL, Schmid RA, Frese S (2010) Inhibition of tissue transglutaminase sensitizes TRAIL-resistant lung cancer cells through upregulation of death receptor 5. FEBS Lett 584:2867–2871 ArticlePubMedCAS Google Scholar
Grenard P, Bresson-Hadni S, El Alaoui S, Chevallier M, Vuitton DA, Ricard-Blum S (2001) Transglutaminase-mediated cross-linking is involved in the stabilization of extracellular matrix in human liver fibrosis. J Hepatol 35:367–375 ArticlePubMedCAS Google Scholar
Griffin M, Casadio R, Bergamini CM (2002) Transglutaminases: nature’s biological glues. Biochem J 368:377–396 ArticlePubMedCAS Google Scholar
Grivennikov S, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140:883–899 ArticlePubMedCAS Google Scholar
Hwang JY, Mangala LS, Fok JY, Lin YG, Merritt WM, Spannuth WA, Nick AM, Fiterman DJ, Vivas-Mejia PE, Deavers MT, Coleman RL, Lopez-Berestein G, Mehta K, Sood AK (2008) Clinical and biological significance of tissue transglutaminase in ovarian carcinoma. Cancer Res 68:5849–5858 ArticlePubMedCAS Google Scholar
Iacobuzio-Donahue CA, Ashfaq R, Maitra A, Adsay NV, Shen-Ong GL, Berg K, Hollingsworth MA, Cameron JL, Yeo CJ, Kern SE, Goggins M, Hruban RH (2003) Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res 63:8614–8622 PubMedCAS Google Scholar
Iismaa SE, Mearns BM, Lorand L, Graham RM (2009) Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders. Physiol Rev 89:991–1023 ArticlePubMedCAS Google Scholar
Janda E, Lehmann K, Killisch I, Jechlinger M, Herzig M, Downward J, Beug H, Grünert S (2002) Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J Cell Biol 156:299–313 ArticlePubMedCAS Google Scholar
Jeanes A, Gottardi CJ, Yap AS (2008) Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene 27:6920–6929 ArticlePubMedCAS Google Scholar
Jiang D, Ying W, Lu Y, Wan J, Zhai Y, Liu W, Zhu Y, Qiu Z, Qian X, He F (2003) Identification of metastasis associated proteins by proteomic analysis and functional exploration of interleukin-18 in metastasis. Proteomics 3:724–737 ArticlePubMedCAS Google Scholar
Johnson TS, Griffin M, Thomas GL, Skill J, Cox A, Yang B, Nicholas B, Birckbichler PJ, Muchaneta-Kubara C, Meguid El Nahas A (1997) The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis. J Clin Invest 99:2950–2960 ArticlePubMedCAS Google Scholar
Johnson K, Hashimoto S, Lotz M, Pritzker K, Terkeltaub R (2001) Interleukin-1 induces pro-mineralizing activity of cartilage tissue transglutaminase and factor XIIIa. Am J Pathol 159:149–163 ArticlePubMedCAS Google Scholar
Johnson TS, EI-Koraie AF, Skill NJ, Baddour NM, EI Nahas AM, Njloma M, Adam AG, Griffin M (2003) Tissue transglutaminase and the progression of human renal scarring. J Am Soc Nephrol 14:2052–2062 ArticlePubMedCAS Google Scholar
Kalluri R (2009) EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest 119:1417–1419 ArticlePubMedCAS Google Scholar
Kalluri R, Neilson EG (2003) Epithelial–mesenchymal transition and its implications for fibrosis. J Clin Invest 112:1776–1784 PubMedCAS Google Scholar
Kumar A, Xu J, Brady S, Gao H, Yu D, Reuben J, Mehta K (2010) Tissue transglutaminase promotes drug resistance and invasion by inducing mesenchymal transition in mammary epithelial cells. PLoS One 5:e13390 ArticlePubMed Google Scholar
Kumar A, Gao H, Xu J, Reuben J, Yu D, Mehta K (2011) Evidence that aberrant expression of tissue transglutaminase promotes stem cell characteristics in mammary epithelial cells. PLoS One 6:e20701 ArticlePubMedCAS Google Scholar
Kuncio GS, Tsyganskaya M, Zhu J, Liu S-L, Nagy L, Thomazy V, Davies PJ, Zern MA (1998) TNF alpha modulates expression of the tissue transglutaminase gene in liver cells. Am J Physiol 274:G240–G245 PubMedCAS Google Scholar
Lee KN, Birckbichler PJ, Patterson MK Jr (1989) GTP hydrolysis by guinea pig liver transglutaminase. Biochem Biophys Res Commun 162:1370–1375 ArticlePubMedCAS Google Scholar
Lee J, Kim YS, Choi DH, Bang MS, Han TR, Joh TH, Kim SY (2004) Transglutaminase 2 induces nuclear factor-κB activation via a novel pathway in BV-2 microglia. J Biol Chem 279:53725–53735 ArticlePubMedCAS Google Scholar
Lesort M, Tucholski J, Miller ML, Johnson GV (2000) Tissue transglutaminase: a possible role in neurodegenerative diseases. Prog Neurobiol 61:439–463 ArticlePubMedCAS Google Scholar
Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, Fong SF, Csiszar K, Giaccia A, Weninger W, Yamauchi M, Gasser DL, Weaver VM (2009) Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139:891–906 ArticlePubMedCAS Google Scholar
Maiuri L, Luciani A, Giardino I, Raia V, Villella VR, D’Apolito M, Pettoello-Mantovani M, Guido S, Ciacci C, Cimmino M, Cexus ON, Londei M, Quaratino S (2008) Tissue transglutaminase activation modulates inflammation in cystic fibrosis via PPARgamma down-regulation. J Immunol 180:7697–7705 PubMedCAS Google Scholar
Mangala LS, Fok JY, Zorrilla-Calancha IR, Verma A, Mehta K (2007) Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells. Oncogene 26:2459–2470 ArticlePubMedCAS Google Scholar
Mann AP, Verma A, Sethi G, Manavathi B, Wang H, Fok JY, Kunnumakkara AB, Kumar R, Aggarwal BB, Mehta K (2006) Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-κB in cancer cells: delineation of a novel pathway. Cancer Res 66:8788–8795 ArticlePubMedCAS Google Scholar
Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer related inflammation. Nature 454:436–444 ArticlePubMedCAS Google Scholar
Mehta K, Eckert R (2005) Transglutaminases—family of enzymes with diverse functions. Prog Exp Tumor Res 38:1–247 ArticlePubMedCAS Google Scholar
Mehta K, Fok J, Miller FR, Koul D, Sahin AA (2004) Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer. Clin Cancer Res 10:8068–8076 ArticlePubMedCAS Google Scholar
Mehta K, Kumar A, Kim HI (2010) Transglutaminase 2: A multi-tasking protein in the complex circuitry of inflammation and cancer. Biochem Pharmacol 80:1921–1929 ArticlePubMedCAS Google Scholar
Nakaoka H, Perez DM, Baek KJ, Das T, Husain A, Misono K, Im MJ, Graham RM (1994) Gh: a GTPbinding protein with transglutaminase activity and receptor signaling function. Science 264:1593–1596 ArticlePubMedCAS Google Scholar
Osika E, Cavaillon JM, Chadelat K, Boule M, Fitting C, Tournier G, Clement A (1999) Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease. Eur Respir J 14:339–346 ArticlePubMedCAS Google Scholar
Park KS, Kim HK, Lee JH, Choi YB, Park SY, Yang SH, Kim SY, Hong KM (2010) Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer. J Cancer Res Clin Oncol 136:493–502 ArticlePubMedCAS Google Scholar
Pinkas DM, Strop P, Brunger AT, Khosla C (2007) Transglutaminase 2 undergoes a large conformational change upon activation. PLoS Biol 5:e327 ArticlePubMed Google Scholar
Quan G, Choi JY, Lee DS, Lee SC (2005) TGF-beta1 upregulates transglutaminase 2 and fibronectin in dermal fibroblasts: a possible mechanism for the stabilization of tissue inflammation. Arch Dermatol Res 297:84–90 ArticlePubMedCAS Google Scholar
Richards RJ, Masek LC, Brown RF (1991) Biochemical and cellular mechanisms of pulmonary fibrosis. Toxicol Pathol 19:526–539 ArticlePubMedCAS Google Scholar
Shao M, Cao L, Shen C, Satpathy M, Chelladurai B, Bigsby RM, Nakshatri H, Matei D (2009) Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminase. Cancer Res 69:9192–9201 ArticlePubMedCAS Google Scholar
Shweke N, Boulos N, Jouanneau C, Vandermeersch S, Melino G, Dussaule JC, Chatziantoniou C, Ronco P, Boffa JJ (2008) Tissue transglutaminase contributes to interstitial renal fibrosis by favoring accumulation of fibrillar collagen through TGF-beta activation and cell infiltration. Am J Pathol 173:631–642 ArticlePubMedCAS Google Scholar
Singh A, Settleman J (2010) EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 29:4741–4751 ArticlePubMedCAS Google Scholar
Thiery JP (2002) Epithelial–mesenchymal transitions in tumour progression. Nat Rev Cancer 2:442–454 ArticlePubMedCAS Google Scholar
Verderio EA, Johnson T, Griffin M (2004) Tissue transglutaminase in normal and abnormal wound healing: review article. Amino Acids 26:387–404 ArticlePubMedCAS Google Scholar
Verderio EA, Johnson TS, Griffin M (2005) Transglutaminases in wound healing and inflammation. Prog Exp Tumor Res 38:89–114 ArticlePubMedCAS Google Scholar
Verma A, Mehta K (2007a) Tissue transglutaminase-mediated chemoresistance in cancer cells. Drug Resist Updat 10:144–151 ArticlePubMedCAS Google Scholar
Verma A, Mehta K (2007b) Transglutaminase-mediated activation of nuclear transcription factor-kappaB in cancer cells: a new therapeutic opportunity. Curr Cancer Drug Targets 7:559–565 ArticlePubMedCAS Google Scholar
Verma A, Wang H, Manavathi B, Fok JY, Mann AP, Kumar R, Mehta K (2006) Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis. Cancer Res 66:10525–10533 ArticlePubMedCAS Google Scholar
Verma A, Guha S, Diagaradjane P, Kunnumakkara AB, Sanguino AM, Lopez-Berestein G, Sood AK, Aggarwal BB, Krishnan S, Gelovani JG, Mehta K (2008) Therapeutic significance of elevated tissue transglutaminase expression in pancreatic cancer. Clin Cancer Res 14:2476–2483 ArticlePubMedCAS Google Scholar
Vincent-Salomon A, Thiery JP (2003) Host microenvironment in breast cancer development: epithelial–mesenchymal transition in breast cancer development. Breast Cancer Res 5:101–106 ArticlePubMedCAS Google Scholar
Yuan L, Choi K, Khosla C, Zheng X, Higashikubo R, Chicoine MR, Rich KM (2005) Tissue transglutaminase 2 inhibition promotes cell death and chemosensitivity in glioblastomas. Mol Cancer Ther 4:1293–1302 ArticlePubMedCAS Google Scholar
Yuan L, Siegel M, Choi K, Khosla C, Miller CR, Jackson EN, Rich KM (2007) Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy. Oncogene 26:2563–2573 ArticlePubMedCAS Google Scholar